Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
4
Bullish
8
Bearish
34
Neutral
4
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q3 FY26

Bharat Rasayan Ltd (BHARATRAS) is currently trading at 932.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Bharat Rasayan Limited is an integrated agrochemical company that manufactures technical grade pesticides, formulations and intermediates, operating legacy manufacturing at Medak and a larger Dahej plant and supplying active ingredients such as fenvalerate, cypermethrin, Metaphenoxy Benzaldehyde, Ethyl Ester and Isoproturon to formulators domestically and for exports. Financials show resilient profitability: standalone Q3 revenue of INR 270.46 crore and nine‑month revenue of INR 933.82 crore, with Q3 standalone PAT of INR 33.99 crore and nine‑month PAT of INR 103.81 crore; operating margins around mid‑teens and EPS materially improved after the share split and bonus issuance. Balance sheet strength is a notable feature: extremely low debt‑equity of 0.06, high net worth (approx. INR 1,20,989 lakh standalone), debt service and interest coverage ratios well above 30x, and credit ratings retained at CARE AA‑ (long) and CARE A1+ (short). Operational risk is concentrated in the Dahej plant where damage to Property, Plant and Equipment (Block‑D) is under an insurance claim; depreciation continues on full book value and FLOP claim will be recognised on receipt, creating timing uncertainty for reparations and profit recognition. Corporate housekeeping actions during the quarter included sub‑division of equity from Rs10 to Rs5 and a 1:1 bonus issue, raising paid‑up equity to 1,66,21,072 shares and restating EPS comparatives, while consolidated reporting recognises BRL’s share of JV profits, underlining shareholder value measures and strategic alliance monetisation.
Over the past 52 weeks, Bharat Rasayan Ltd has traded between a low of ₹922.80 and a high of ₹2,844.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Bharat Rasayan Ltd has a market capitalization of approximately 1,577.67. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Bharat Rasayan Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 11.01 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,577.67 Cr, Bharat Rasayan Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Bharat Rasayan Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Bharat Rasayan Ltd is 11.01. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The snapshot shows revenue of ₹308 crore and net profit of ₹39 crore for Q4 FY26 (quarter ended Mar 2026), with the earnings date listed as May 26, 2026.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
1,549 Cr
High Risk
10.8
18.4
3.6
1.2
2,844.00
922.80
Sales CAGR
Profit CAGR
ROE
ROCE